Author/Authors :
Niemczyk, Mariusz Department of Immunology - Transplant Medicine and Internal Diseases - Medical University of Warsaw, Poland
Abstract :
I would like to comment on the paper by Beiraghdar et
al. (1). C2 is regarded as a better indicator of cyclosporine
A (CsA) exposure compared to C0 (2), this is also the case
in pediatric patients (3). however, in clinical settings, C0
monitoring seems to be more reliable. It is connected to
the fact that, CsA blood concentration is quite stable for
between 10 and 12 hours after administration, and the
collection of blood during that time allows valuable clinical
results to be obtained. on the other hand, the peak
concentration is obtained 2 hours after administration
only in a limited group of patients, so called “good absorbers.”
In delayed absorbers, C2 is not fully reliable(4).